Biogenerics Would Reduce Health Care Costs For Patients, Says GPhA The Generic Pharmaceutical Association (GPhA) today said the availability of a workable pathway that provides timely patient access to safe, affordable and life-saving biogeneric
medicines would save consumers and the
health care system billions of dollars. The skyrocketing prices of certain
prescription drugs were the focus of a Joint Economic Committee hearing on Capitol Hill yesterday (www.jec.senate.gov).
Source: www.medicalnewstoday.comNew Report Examines Current Use And Future Impact On Global Clinical And Reimbursement Practices Research and Markets has announced the addition of the "Evidence-Based
Medicine - Current Use and Future Impact on Global Clinical and Reimbursement Practices" report to their offering. Evidence-based
medicine is defined as an attempt to use standards from scientifically-collected evidence to improve medical practices by assessing risks and benefits of treatments and/or the lack of treatments.
Source: www.medicalnewstoday.comMore Participants Sought For Study Of Prolotherapy For Tennis Elbow At UPMC The Center for Integrative
Medicine (CIM) at the University of Pittsburgh Medical Center (UPMC) is seeking participants for a study to evaluate the benefits of prolotherapy for tennis elbow. Prolotherapy is a non-surgical treatment used to stimulate repair of damaged ligaments and tendons. It uses an irritant such as a sugar-based solution that is injected into the deep tissue structures.
Source: www.medicalnewstoday.comRegional Factors Driven By Genetic Diversity Add Complexity To Autoimmune Disease Drug Development As a group, autoimmune diseases remain one of the most refractory and difficult-to-treat segments of
healthcare therapeutics. The underlying genetics of the immune response and the complexities they foster among individual patients make this one of the most challenging areas in all of life science. Until recently, autoimmune disease patients were given little hope for effective treatment.
Source: www.medicalnewstoday.comBioPharm America Unveils Conference Program With only two months until the start of BioPharm America(TM) in Atlanta, September 9-10, 2008, EBD Group today announced the conference's program highlights covering a wide selection of important industry topics. The eagerly anticipated BioPharm America partnering conference is expected to bring out many well known and respected names in the biotech industry and to be the most international stand-alone partnering event held on US soil.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 AM
